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Micro-CT provides 3D volume imaging with spatial resolution at the micrometre scale. We investigated
the optimal human placenta tissue preparation (contrast agent, perfusion pressure, perfusion location
and perfusion vessel) and imaging (energy, target material, exposure time and frames) parameters.
Microﬁl (Flow Tech, Carver, MA) produced better ﬁll than Barium sulphate (84.1%(±11.5%)
vs70.4%(±18.02%) p ¼ 0.01). Perfusion via umbilical artery produced better ﬁll than via chorionic vessels
(83.8%(±17.7%)vs78.0%(±21.9%), p < 0.05), or via umbilical vein (83.8%(±16.4%)vs69.8%(±20.3%), p < 0.01).
Imaging at 50 keV with a molybdenum target produced the best contrast to noise ratio. We propose this
method to enable quantiﬁcation and comparison of the human fetoplacental vascular tree.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Fetal health and development is intricately bound with human
placental circulation, yet there is no validated quantitative method
with which to assess vascularisation of the human placenta.
Developing a quantitative method may improve our ability to
investigate, and therefore understand, normal placental function
and pathologies such as fetal growth restriction, stillbirth and twin-
to-twin transfusion syndrome.
Micro-focus Computed Tomography (micro-CT) provides three-
dimensional volume imaging with spatial resolution at the micro-
metre scale. The technique has been used to investigate the
branching structure and tortuosity of the fetoplacental circulationup, Dept. Medical Physics and Biom
.
ht and guidance of this work.
r Ltd. This is an open access articleof mouse placentae [1] [2], and shown differences in vascular
density of the human placenta between normally grown and
growth restricted pregnancies [3], [4].
This study was designed to develop optimised tissue-speciﬁc
preparation and micro-CT imaging parameters, in order to pro-
vide a validated approach to human placenta micro-CT.2. Method
This series of experiments is divided into two sections; inves-
tigating tissue preparation techniques, and then micro-CT imaging
parameters. The full experimental methodology is described in
supplementary data.edical Engineering, University College London, Malet Place Engineering Building,
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Experimental procedures were approved by Bloomsbury Na-
tional Research Ethics Service Committee and by University College
London Hospital Research and Development (REC Reference
number 133888). Placentas delivered by elective term caesarean
section were taken directly to the laboratory, had the membranes
trimmed, and the amnion removed.Vascular Fill ð%Þ ¼

Total Perfused Vessel Area
Total Perfused Vessel Areaþ Total Unperfused Vessel Area

 100 (1)2.2. Tissue preparation comparators
We designed experiments to compare (Table 1):
 Contrast agent e comparing Barium sulphate with Microﬁl
(Flow Tech, Carver, MA.).
 Perfusion pressure e comparing manual pressure with no
quantiﬁcation of perfusion pressure, with controlled pressure of
60 mmHg, physiologically relevant to fetal life [5e7].
 Cannulation location e comparing perfusion via the umbilical
artery with perfusion via a chorionic artery.
 Arterial or Venous Cannulation e comparing perfusion via
cannulation of the umbilical artery with perfusion via the um-
bilical vein.
The fetal vessel of interest was cannulated, and a cutmade in the
main draining vessel close to the point of cannulation, to create a
ﬂuid exit vent. 0.9% sodium chloride solution with 5IU heparin/ml
was perfused until the outﬂow ran clear, then contrast agent was
perfused until the chorionic vasculature was fully perfused and
contrast agent was seen in the draining vessel. The vessel wasTable 1
Comparison of placental tissue preparation and micro-CT imaging parameters used in th
results of this study. SNR ¼ signal to noise ratio.
Langheinrich [4]
(Human)
Rennie et al.[10]
(Mouse)
Assessme
Tissue Preparation
Contrast Agent Microﬁl and BaSO4 in
gelatin
Microﬁl Microﬁl a
Perfusion Pressure
(mmHg)
74 Not reported Manual p
Perfusion Location Chorionic (peripheral)
perfusion
Umbilical (central)
Perfusion
Chorionic
(central)
Perfusion Vessel Chorionic plate artery Umbilical Artery/
Umbilical Vein
Chorionic
vein
Tissue sampling
technique
8  2 mm full thickness
blocks
Whole placenta 8  2 cm
Micro CT Imaging
Cone-beam energy
(keV)
60 80 30-100 in
Target material Not reported Not reported Tungsten
Isotropic voxel size (mm) 13 and 4 13 13
Radiograph exposure
time (ms)
2400 Not reported 500/1000
Number of projections 400 720 3141/628occluded and the contrast agent was left to set. The placenta was
dissected into 2 2cm full thickness blocks, which were ﬁxed in 4%
formalin for a minimum of 48 h. One full thickness section stained
with hematoxylin and eosin (H&E) was cut for every block and 6
micrographs at x100 magniﬁcation taken (see supplementary
material).
Histological analysis was done in FIJI (ImageJ Version 2.0.0-rc-
54/1.51f) [8]. Vascular ﬁll was calculated for each micrograph as
shown in equation one.2.3. Micro-CT imaging comparators
We designed experiments to compare (Table 1).
 Energy level e from 30 to 100 keV in 10 keV increments.
 Target material e comparing Tungsten, Copper and
Molybdenum.
 Exposure timee500 and 1000 ms
 Averaged frames per projectione1 and 2
A 2  2cm full thickness block of human placenta was repeat-
edly imaged (XT H 225 ST Micro-CT, Nikon Metrology, Tring, UK)
adjacent to a 3 mm internal diameter tube ﬁlled with Microﬁl.
Scans were reconstructed using a modiﬁed Feldkamp ﬁltered back
projection algorithm with proprietary software (CTPro3D; Nikon
Meterology), and the average greyscale values of recorded areas of
interest drawn over placenta, Microﬁl and air were calculated. The
contrast to noise ratio was calculated as shown in equation two.is study and in two previous studies, and optimised protocol as determined by the
nt Parameters Optimised Protocol
nd BaSO4 in gelatin Microﬁl
ressure and 60 No difference Manual and 60 mmHg give
equivalent results
(peripheral) and umbilical
perfusion
Central vessel, ideally umbilical vessel
artery/Umbilical artery/Umbilical Artery
full thickness blocks Dependent on magniﬁcation and ﬁeld of view
required
10 keV increments 50
, Molybdenum, Copper Molybdenum
Dependent on magniﬁcation and ﬁeld of view
required
Balance with throughput 1000 gives good SNR
2/12564 Balance with throughput
3141 gives good SNR
Contrast to Noise ratio ðCNRÞ ¼ ðPlacenta Grey Scale ValueMicrofil Grey Scale ValueÞ
Standard Deviation of Signal of Air
(2)
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Data is presented as mean ± SD. Statistical analysis was done in
SPSS Statistics (IBM version 23). Group comparison was performed
using independent sample t-tests with signiﬁcance set at 95%.
3. Results
3.1. Tissue preparation comparators
There was lower mean vascular ﬁll with barium sulphate than
Microﬁl (70.4% (±18.02%) BaSo4 vs 84.1% (±11.5%) Microﬁl,
(p¼ 0.01)) and barium sulphatewas seen in the extravascular space
in all three blocks sampled (47% of micrographs), whereas Microﬁl
was never seen in the extravascular space.
There was no signiﬁcant difference in vascular ﬁll between
manual or controlled 60 mmHg perfusion pressure (77.8%(±13.9%)
manual vs 78.0%(±21.9%) controlled pressure p ¼ 0.95). Perfusion
via an umbilical artery achieved higher vascular ﬁll than perfusion
via a more peripheral chorionic vessel (83.8%(±17.7%) umbilical
artery vs 78.0%(±21.9%) chorionic artery, p < 0.05). Umbilical
arterial perfusion produced higher vascular ﬁll than umbilical
venous perfusion (83.8%(±16.4%) umbilical artery vs 69.8%(±20.3%)Fig. 1. Identifying optimal micro-CT imaging parameters for Contrast to Noise Ratio (CNR)
arbitrary units) between placenta and Microﬁl grey scale value with increasing energy for M
image noise, with increasing energy for Molybdenum, Tungsten and Copper target. C: Contr
D: Effect of increasing the exposure time and the averaged frames per projection on the CNumbilical vein p < 0.01) (see Table 1 for summary, and supple-
mentary data Table 1 for full results).
3.2. Micro-CT imaging parameters
Contrast and noise were both greatest at the lower energy levels
(Fig. 1A/B). The optimal CNR was with Molybdenum target at
50 keV (Fig. 1C). Increasing exposure time from 500 ms to 1000 ms
and averaged frames per projection reduced the noise and
improved the CNR (Fig. 1D) at the cost of imaging time and
throughput (Table 1).
4. Discussion
We have established optimal tissue and imaging parameters for
placental angiographic micro-CT (Table 1). Our studies show that
Microﬁl is a superior contrast agent to barium suphate, and that
central and arterial perfusion are superior to peritheral and venous
perfusion. Contrast to noise ratio is optimal when imaging with
50 keV energy, with a Molybdenum target. Increasing the number
of projection and exposure time improves CNR at the cost of
throughput. Our studies found 1000 ms exposure time and 3141
projections over 360 rotation produced good CNR with a 54 min. A: Contrast (deﬁned as Microﬁl Grey Scale value e placental issue Grey Scale value,
olybdenum, Tungsten and Copper target. B: Standard deviation of the signal in air, the
ast to noise ratio with increasing energy for Molybdenum, Tungsten and Copper target.
R.
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This approach can be used to investigate the microcirculation of
the human placenta. The technique beneﬁts from its high resolu-
tion and large ﬁeld of view, allowing images of the vascular tree to
be captured from the chorionic plate to the intermediate villous
vessels (see supplementary data for images).
Micro-CT allows measurement of vascular density and analysis
of the structure of the vascular trees, which could improve our
understanding of the heterogeneity within normal placentae, and
the structural changes associated with diseases such as early and
late intrauterine growth restriction.
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